An NMR based panorama of the heterogeneous biology of acute respiratory distress syndrome (ARDS) from the standpoint of metabolic biomarkers.
ARDS
NMR
biomarker
chemometrics
critical care
metabolomics
phenotype
respiratory diseases
Journal
NMR in biomedicine
ISSN: 1099-1492
Titre abrégé: NMR Biomed
Pays: England
ID NLM: 8915233
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
13
05
2019
revised:
16
08
2019
accepted:
05
09
2019
pubmed:
17
11
2019
medline:
8
1
2021
entrez:
17
11
2019
Statut:
ppublish
Résumé
Acute respiratory distress syndrome (ARDS), manifested by intricate etiology and pathophysiology, demands careful clinical surveillance due to its high mortality and imminent life support measures. NMR based metabolomics provides an approach for ARDS which culminates from a wide spectrum of illness thereby confounding early manifestation and prognosis predictors.
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e4192Informations de copyright
© 2019 John Wiley & Sons, Ltd.
Références
Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016;388(10058):2416-2430.
Piantadosi CA, Schwartz DA. The Acute Respiratory Distress Syndrome. Ann Intern Med. 2004;141(6):460-470.
Young L, O'Sullivan F. Acute respiratory distress syndrome. Anaesth Intens Care Med. 2016;17(10):526-528.
Villar J, Blanco J, Kacmarek RM. Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care. 2016;22(1):1-6.
Ashbaugh D, Boyd Bigelow D, Petty T, Levine B. Acute Respiratory Distress in Adults. Lancet. 1967;290(7511):319-323.
Walkey AJ, Summer R, Ho V, Alkana P. Acute respiratory distress syndrome: epidemiology and management approaches. Clin Epidemiol. 2012;4:159-169.
Ware LB, Matthay MA. The Acute Respiratory Distress Syndrome. N Engl J Med. 2000;342(18):1334-1349.
Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest. 2007;131(2):554-562.
Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012;122(8):2731-2740.
Slutsky AS, Marco Ranieri V. Mechanical ventilation: lessons from the ARDSNet trial. Respir Res. 2000;1(2):2.
Koh Y. Update in acute respiratory distress syndrome. J Intensive Care. 2014;2(1):2.
Matthay MA, Zimmerman GA. Acute Lung Injury and the Acute Respiratory Distress Syndrome. Am J Respir Cell Mol Biol. 2005;33(4):319-327.
Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151(2 Pt 1):293-301.
Silversides JA, Ferguson ND. Clinical review: Acute respiratory distress syndrome - clinical ventilator management and adjunct therapy. Crit Care. 2013;17(2):225-225.
Fan E, Needham DM, Stewart TE. Ventilatory management of acute lung injury and acute respiratory distress syndrome. JAMA. 2005;294(22):2889-2896.
Wyncoll DLA, Evans TW. Acute respiratory distress syndrome. Lancet. 1999;354(9177):497-501.
Cranshaw J, Griffiths MJD, Evans TW. The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS. Thorax. 2002;57(9):823-829.
Máca J, Jor O, Holub M, et al. Past and Present ARDS Mortality Rates: A Systematic Review. Respir Care. 2017;62(1):113-122.
Estenssoro E, Dubin A, Laffaire E, et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med. 2002;30(11):2450-2456.
Bersten AD, Edibam C, Hunt T, Moran J. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian States. Am J Respir Crit Care Med. 2002;165(4):443-448.
Villar J, Blanco J, Añón J, et al. The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med. 2011;37(12):1932-1941.
Esteban A, Frutos-Vivar F, Muriel A, et al. Evolution of Mortality over Time in Patients Receiving Mechanical Ventilation. Am J Respir Crit Care Med. 2013;188(2):220-230.
Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med. 2009;37(5):1574-1579.
Tsushima K, King LS, Aggarwal NR, De Gorordo A, D'Alessio FR, Kubo K. Acute Lung Injury Review. Intern Med. 2009;48(9):621-630.
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788-800.
Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and Outcomes of Acute Lung Injury. N Engl J Med. 2005;353(16):1685-1693.
Wang CY, Calfee CS, Paul DW, et al. One-year mortality and predictors of death among hospital survivors of the Acute Respiratory Distress Syndrome. Intensive Care Med. 2014;40(3):388-396.
Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. The Lancet, Saturday 12 August 1967. Crit Care Resusc. 2005;7(1):60-61.
Ferguson ND, Frutos-Vivar F, Esteban A, et al. Acute respiratory distress syndrome: Underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med. 2005;33(10):2228-2234.
Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573-1582.
Herridge MS. Fifty Years of Research in ARDS.Long-Term Follow-up after Acute Respiratory Distress Syndrome. Insights for Managing Medical Complexity after Critical Illness. Am J Respir Crit Care Med. 2017;196(11):1380-1384.
Laffey JG, Kavanagh BP. Fifty Years of Research in ARDS. Insight into Acute Respiratory Distress Syndrome. From Models to Patients. Am J Respir Crit Care Med. 2017;196(1):18-28.
Slutsky AS, Villar J, Pesenti A. Happy 50th birthday ARDS! Intensive Care Med. 2016;42(5):637-639.
Pham T, Rubenfeld GD. Fifty Years of Research in ARDS. The Epidemiology of Acute Respiratory Distress Syndrome. A 50th Birthday Review. Am J Respir Crit Care Med. 2017;195(7):860-870.
Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138(3):720-723.
Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-824.
The ADTF, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: The berlin definition. JAMA. 2012;307(23):2526-2533.
Villar J, Slutsky AS. GOLDEN anniversary of the acute respiratory distress syndrome: still much work to do! Curr Opin Crit Care. 2017;23(1):4-9.
Fioretto JR, Carvalho WB. Evolução temporal das definições de síndrome do desconforto respiratório agudo. J Pediatr (Rio J). 2013;89:523-530.
Chiumello D, Brochard L, Marini JJ, et al. Respiratory support in patients with acute respiratory distress syndrome: an expert opinion. Crit Care. 2017;21(1):240.
Taylor MM. ARDS Diagnosis and Management: Implications for the Critical Care Nurse. Dimens Crit Care Nurs. 2005;24(5):197-207.
Klein Y, Blackbourne L, Barquist ES. Non-Ventilatory-Based Strategies in the Management of Acute Respiratory Distress Syndrome. J Trauma Acute Care Surg. 2004;57(4):915-924.
http://www.ardsil.com/acute-respiratory-distress-syndrome.htm.
Matthay MA, Zimmerman GA. Acute Lung Injury and the Acute Respiratory Distress Syndrome: Four Decades of Inquiry into Pathogenesis and Rational Management. Am J Respir Cell Mol Biol. 2005;33(4):319-327.
Xu W, Song Y. Biomarkers for patients with trauma associated acute respiratory distress syndrome. Mil Med Res. 2017;4:25.
Cross LJM, Matthay MA. Biomarkers in Acute Lung Injury: Insights into the Pathogenesis of Acute Lung Injury. Crit Care Clin. 27(2):355-377.
Sweeney TE, Khatri P. Generalizable Biomarkers in Critical Care: Toward Precision Medicine. Crit Care Med. 2017;45(6):934-939.
Binnie A, Tsang JLY, dos Santos CC. Biomarkers in acute respiratory distress syndrome. Curr Opin Crit Care. 2014;20(1):47-55.
Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med. 1997;155(4):1187-1205.
Tunceroglu H, Shah A, Porhomayon J, Nader ND. Biomarkers of Lung Injury in Critical Care Medicine: Past, Present, and Future. Immunol Invest. 2013;42(3):247-261.
Cribbs SK, Martin GS. Biomarkers in acute lung injury: are we making progress? Crit Care Med. 2008;36(8):2457-2459.
Fujishima S. Pathophysiology and biomarkers of acute respiratory distress syndrome. J Intensive Care. 2014;2(1):32.
Falagas ME, Zarkadoulia EA, Bliziotis IA, Samonis G. Science in Greece: from the age of Hippocrates to the age of the genome. FASEB J. 2006;20(12):1946-1950.
White WI. A new look at the role of urinalysis in the history of diagnostic medicine. Clin Chem. 1991;37(1):119-125.
Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature. 2008;455(7216):1054-1056.
Gebregiworgis T, Powers R. Application of NMR Metabolomics to Search for Human Disease Biomarkers. Comb Chem High Throughput Screen. 2012;15(8):595-610.
García-Laorden MI, Lorente JA, Flores C, Slutsky AS, Villar J. Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise. Ann Trans Med. 2017;5(14):283.
Ware LB, Zhao Z, Koyama T, et al. Derivation and validation of a two-biomarker panel for diagnosis of ARDS in patients with severe traumatic injuries. Trauma Surg Acute Care Open. 2017;2(1).
Butt Y, Kurdowska A, Allen TC. Acute Lung Injury: A Clinical and Molecular Review. Arch Pathol Lab Med. 2016;140(4):345-350.
Agouridakis P, Kyriakou D, Alexandrakis MG, et al. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res. 2002;3(1):25-25.
Serkova NJ, Standiford TJ, Stringer KA. The Emerging Field of Quantitative Blood Metabolomics for Biomarker Discovery in Critical Illnesses. Am J Respir Crit Care Med. 2011;184(6):647-655.
Bouros D, Alexandrakis MG, Antoniou KM, et al. The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome. BMC Pulm Med. 2004;4:6.
Tzouvelekis A, Pneumatikos I, Bouros D. Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator. Respir Res. 2005;6(1):62.
Bos LDJ, Weda H, Wang Y, et al. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome. Eur Respir J. 2014;44(1):188-197.
Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld ABJ. Plasma Biomarkers for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis*. Crit Care Med. 2014;42(3):691-700.
Abadie Y, Bregeon F, Papazian L, et al. Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J. 2005;25(1):139-146.
Albertine KH, Soulier MF, Wang Z, et al. Fas and Fas Ligand Are Up-Regulated in Pulmonary Edema Fluid and Lung Tissue of Patients with Acute Lung Injury and the Acute Respiratory Distress Syndrome. Am J Pathol. 2002;161(5):1783-1796.
Levitt JE, Gould MK, Ware LB, Matthay MA. The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury. J Intensive Care Med. 2009;24:151-167.
Bhargava M, Wendt CH. Biomarkers in acute lung injury. Transl Res. 159(4):205-217.
Barnett N, Ware LB. Biomarkers in Acute Lung Injury-Marking Forward Progress. Crit Care Clin. 2011;27(3):661-683.
Ware LB, Calfee CS. Biomarkers of ARDS: what's new? Intensive Care Med. 2016;42(5):797-799.
Budinger GRS, Kohanski RA, Gan W, et al. The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop. J Gerontol A Biol Sci Med Sci. 2017;72(11):1492-1500.
Gattinoni L, Quintel M. Fifty Years of Research in ARDS Why Is Acute Respiratory Distress Syndrome So Important for Critical Care? Am J Respir Crit Care Med. 2016;194(9):1051-1052.
Nicholson JK, Wilson ID. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003;2(8):668-676.
Gehlenborg N, O'Donoghue SI, Baliga NS, et al. Visualization of omics data for systems biology. Nat Methods. 2010;7(3 Suppl):S56-S68.
Nicholson JK. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol. 2006;2:52-52.
Kell DB. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today. 2006;11(23-24):1085-1092.
Kell DB, Brown M, Davey HM, Dunn WB, Spasic I, Oliver SG. Metabolic footprinting and systems biology: the medium is the message. Nat Rev Microbiol. 2005;3(7):557-565.
Stringer KA, McKay RT, Karnovsky A, Quémerais B, Lacy P. Metabolomics and Its Application to Acute Lung Diseases. Front Immunol. 2016;7:44.
Zhou T, Garcia JGN, Zhang W. Integrating microRNAs into a system biology approach to acute lung injury. Transl Res. 2011;157(4):180-190.
Chen C, Shi L, Li Y, Wang X, Yang S. Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. Cell Biol Toxicol. 2016;32(3):169-184.
Nickler M, Ottiger M, Steuer C, et al. Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res. 2015;16:125.
Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998;16(9):373-378.
Tweeddale H, Notley-McRobb L, Ferenci T. Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool ("metabolome") analysis. J Bacteriol. 1998;180(19):5109-5116.
Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition Chromatography. Proc Natl Acad Sci. 1971;68(10):2374-2376.
Horning EC, Horning MG. Metabolic Profiles: Gas-Phase Methods for Analysis of Metabolites. Clin Chem. 1971;17(8):802-809.
Behar KL, den Hollander JA, Stromski ME, et al. High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci. 1983;80(16):4945-4948.
Howells SL, Maxwell RJ, Peet AC, Griffiths JR. An investigation of tumor 1H nuclear magnetic resonance spectra by the application of chemometric techniques. Magn Reson Med. 1992;28(2):214-236.
Hoult DI, Busby SJ, Gadian DG, Radda GK, Richards RE, Seeley PJ. Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature. 1974;252(5481):285-287.
Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH. Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J. 1984;217(2):365-375.
Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29(11):1181-1189.
Lindon JC, Holmes E, Nicholson JK. Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn. 2004;4(2):189-199.
Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, Lindon JC. Metabolic phenotyping in clinical and surgical environments. Nature. 2012;491(7424):384-392.
Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17(7):451-459.
Patti GJ, Yanes O, Siuzdak G. Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13:263.
Mamas M, Dunn WB, Neyses L, Goodacre R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol. 2011;85(1):5-17.
Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011;40(1):387-426.
Dettmer K, Hammock BD. Metabolomics--a new exciting field within the "omics" sciences. Environ Health Perspect. 2004;112(7):A396-A397.
Fiehn O. Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1-2):155-171.
Vinayavekhin N, Homan EA, Saghatelian A. Exploring disease through metabolomics. ACS Chem Biol. 2010;5(1):91-103.
Zhang A, Sun H, Wang P, Han Y, Wang X. Modern analytical techniques in metabolomics analysis. Analyst. 2012;137(2):293-300.
Wishart DS, Feunang YD, Marcu A, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46(Database issue):D608-D617.
Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 2004;22(5):245-252.
Dunn WB, Ellis DI. Metabolomics: Current analytical platforms and methodologies. TrAC Trends Anal Chem. 2005;24(4):285-294.
Dunn WB, Bailey NJ, Johnson HE. Measuring the metabolome: current analytical technologies. Analyst. 2005;130(5):606-625.
Bingol K. Recent Advances in Targeted and Untargeted Metabolomics by NMR and MS/NMR Methods. High-throughput. 2018;7(2).
Markley JL, Bruschweiler R, Edison AS, et al. The future of NMR-based metabolomics. Curr Opin Biotechnol. 2017;43:34-40.
Marchand J, Martineau E, Guitton Y, Dervilly-Pinel G, Giraudeau P. Multidimensional NMR approaches towards highly resolved, sensitive and high-throughput quantitative metabolomics. Curr Opin Biotechnol. 2017;43:49-55.
Eghbalnia HR, Romero PR, Westler WM, Baskaran K, Ulrich EL, Markley JL. Increasing rigor in NMR-based metabolomics through validated and open source tools. Curr Opin Biotechnol. 2017;43:56-61.
Dumas ME, Maibaum EC, Teague C, et al. Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal Chem. 2006;78(7):2199-2208.
Dona AC, Kyriakides M, Scott F, et al. A guide to the identification of metabolites in NMR-based metabonomics/metabolomics experiments. Comput Struct Biotechnol J. 2016;14:135-153.
Dona AC, Jimenez B, Schafer H, et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal Chem. 2014;86(19):9887-9894.
Lindon JC, Nicholson JK, Holmes E, Everett JR. Metabonomics: Metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn Reson. 2000;12(5):289-320.
Ala-Korpela M. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool. Expert Rev Mol Diagn. 2007;7(6):761-773.
Nicholson JK, Wilson ID. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog Nucl Magn Reson Spectrosc. 1989;21(4):449-501.
Serkova NJ, Niemann CU. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn. 2006;6(5):717-731.
Beckonert O, Keun HC, Ebbels TM, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2(11):2692-2703.
Ross A, Schlotterbeck G, Dieterle F, Senn H. Chapter 3 - NMR Spectroscopy Techniques for Application to Metabonomics. In: Lindon JC, Nicholson JK, Holmes E, eds. The Handbook of Metabonomics and Metabolomics. Amsterdam: Elsevier Science B.V; 2007:55-112.
Larive CK, Barding GA, Dinges MM. NMR Spectroscopy for Metabolomics and Metabolic Profiling. Anal Chem. 2015;87(1):133-146.
Snytnikova OA, Khlichkina AA, Sagdeev RZ, Tsentalovich YP. Evaluation of sample preparation protocols for quantitative NMR-based metabolomics. Metabolomics. 2019;15(6):84.
Nagana Gowda GA, Raftery D. Quantitating metabolites in protein precipitated serum using NMR spectroscopy. Anal Chem. 2014;86(11):5433-5440.
Brennan L. NMR-based metabolomics: from sample preparation to applications in nutrition research. Prog Nucl Magn Reson Spectrosc. 2014;83:42-49.
Wishart DS. Quantitative Metabolomics Using NMR. TrAC Trends Anal Chem. 2008;27:228-237.
Vignoli A, Ghini V, Meoni G, et al. High-throughput metabolomics by 1D NMR. Angew Chem Int Ed. 58(4):968-994.
Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem. 2006;78(13):4430-4442.
Hore PJ. [3] Solvent suppression. In: Methods in Enzymology. Vol.176 New York: Academic Press; 1989:64-77.
Piotto M, Saudek V, Sklenar V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR. 1992;2(6):661-665.
Smallcombe SH, Patt SL, Keifer PA. WET Solvent Suppression and Its Applications to LC NMR and High-Resolution NMR Spectroscopy. J Magn Reson A. 1995;117(2):295-303.
Mckay RT. How the 1D-NOESY suppresses solvent signal in metabonomics NMR spectroscopy: An examination of the pulse sequence components and evolution. Concept Magn Reson Part A. 2011;38A(5):197-220.
Meiboom S, Gill D. Modified Spin-Echo Method for Measuring Nuclear Relaxation Times. Rev Sci Instrum. 1958;29(8):688-691.
Keun HC, Beckonert O, Griffin JL, et al. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem. 2002;74(17):4588-4593.
Jones JG, Solomon MA, Sherry AD, Jeffrey FM, Malloy CR. 13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen. Am J Physiol. 1998;275(5 Pt 1):E843-E852.
Aue WP, Bartholdi E, Ernst RR. Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J Chem Phys. 1976;64(5):2229-2246.
Kumar A, Ernst RR, Wuthrich K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun. 1980;95(1):1-6.
Bingol K, Brüschweiler R. Multidimensional Approaches to NMR-Based Metabolomics. Anal Chem. 2014;86(1):47-57.
Kruk J, Doskocz M, Jodłowska E, et al. NMR Techniques in Metabolomic Studies: A Quick Overview on Examples of Utilization. Appl Magn Reson. 2017;48(1):1-21.
Mahrous EA, Farag MA. Two dimensional NMR spectroscopic approaches for exploring plant metabolome: A review. J adv Res. 2015;6(1):3-15.
Ludwig C, Viant MR. Two-dimensional J-resolved NMR spectroscopy: review of a key methodology in the metabolomics toolbox. Phytochem Anal. 2010;21(1):22-32.
Viant MR. Improved methods for the acquisition and interpretation of NMR metabolomic data. Biochem Biophys Res Commun. 2003;310(3):943-948.
Braunschweiler L, Ernst RR. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J Magn Reson (1969). 1983;53(3):521-528.
Palmer AG, Cavanagh J, Wright PE, Rance M. Sensitivity improvement in proton-detected two-dimensional heteronuclear correlation NMR spectroscopy. J Magn Reson (1969). 1991;93(1):151-170.
Bax A, Summers MF. Proton and carbon-13 assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J Am Chem Soc. 1986;108(8):2093-2094.
Bharti SK, Roy R. Quantitative 1H NMR spectroscopy. TrAC Trends Anal Chem. 2012;35:5-26.
Ulrich EL, Akutsu H, Doreleijers JF, et al. BioMagResBank. Nucleic Acids Res. 2008;36(suppl 1):D402-D408.
Xia J, Bjorndahl T, Tang P, Wishart D. MetaboMiner - semi-automated identification of metabolites from 2D NMR spectra of complex biofluids. BMC Bioinform. 2008;9(1):507.
Moco S, Vervoort J, Moco S, Bino RJ, De Vos RCH, Bino R. Metabolomics technologies and metabolite identification. TrAC Trends Anal Chem. 2007;26(9):855-866.
Akoka S, Barantin L, Trierweiler M. Concentration Measurement by Proton NMR Using the ERETIC Method. Anal Chem. 1999;71(13):2554-2557.
Smolinska A, Blanchet L, Buydens LMC, Wijmenga SS. NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review. Anal Chim Acta. 2012;750:82-97.
Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res. 2007;6(2):469-479.
Assfalg M, Bertini I, Colangiuli D, et al. Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci. 2008;105(5):1420-1424.
Worley B, Powers R. Multivariate Analysis in Metabolomics. Curr Metabol. 2013;1(1):92-107.
Alonso A, Marsal S, Julià A. Analytical Methods in Untargeted Metabolomics: State of the Art in 2015. Front Bioeng Biotechnol. 2015;3:23.
Ren S, Hinzman AA, Kang EL, Szczesniak RD, Lu LJ. Computational and statistical analysis of metabolomics data. Metabolomics. 2015;11(6):1492-1513.
Pearson KL III. On lines and planes of closest fit to systems of points in space. Lond Edinb Dubl Phil Mag J Sci. 1901;2(11):559-572.
Hotelling H. Analysis of a complex of statistical variables into principal components. J Educ Psychol. 1933;24.
Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Transact A Math Phys Eng Sci. 2016;374(2065):20150202.
Wold S, Sjöström M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom Intel Lab Syst. 2001;58(2):109-130.
Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemometr. 2002;16(3):119-128.
Xi B, Gu H, Baniasadi H, Raftery D. Statistical analysis and modeling of mass spectrometry-based metabolomics data. Method Mol Biol (Clifton, NJ). 2014;1198:333-353.
Westerhuis JA, Hoefsloot HCJ, Smit S, et al. Assessment of PLSDA cross validation. Metabolomics. 2008;4(1):81-89.
Bijlsma S, Bobeldijk I, Verheij ER, et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem. 2006;78(2):567-574.
López-López Á, López-Gonzálvez Á, Barker-Tejeda TC, Barbas C. A review of validated biomarkers obtained through metabolomics. Expert Rev Mol Diagn. 2018;18(6):557-575.
Fischer K, Kettunen J, Würtz P, et al. Biomarker Profiling by Nuclear Magnetic Resonance Spectroscopy for the Prediction of All-Cause Mortality: An Observational Study of 17,345 Persons. PLoS Med. 2014;11(2):e1001606.
Emwas A-HM, Salek RM, Griffin JL, Merzaban J. NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations. Metabolomics. 2013;9(5):1048-1072.
Nin N, Izquierdo-García JL, Lorente JA. The Metabolomic Approach to the Diagnosis of Critical Illness. In: Vincent J-L, ed. Annual Update in Intensive Care and Emergency Medicine 2012. Vol.2012 Berlin Heidelberg: Springer; 2012:43-52.
Banoei MM, Donnelly SJ, Mickiewicz B, Weljie A, Vogel HJ, Winston BW. Metabolomics in critical care medicine: a new approach to biomarker discovery. Clin Investig Med. 2014;37(6):E363-E376.
Fang X, Bai C, Wang X. Bioinformatics insights into acute lung injury/acute respiratory distress syndrome. Clin Transl Med. 2012;1(1):1-9.
Rogers AJ, McGeachie M, Baron RM, et al. Metabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients. PLoS ONE. 2014;9(1):e87538.
Adamko DJ, Sykes BD, Rowe BH. The Metabolomics of Asthma: Novel Diagnostic Potential. Chest. 2012;141(5):1295-1302.
Luxon BA. Metabolomics in asthma. Adv Exp Med Biol. 2014;795:207-220.
Pite H, Morais-Almeida M, Rocha SM. Metabolomics in asthma: where do we stand? Curr Opin Pulm Med. 2018;24(1):94-103.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
Nobakht MGBF, Aliannejad R, Rezaei-Tavirani M, Taheri S, Oskouie AA. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers. 2015;20(1):5-16.
Cilloniz C, Ferrer M, Liapikou A, et al. Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia. Eur Respir J. 2018;51(3).
Slupsky CM, Rankin KN, Fu H, et al. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res. 2009;8(12):5550-5558.
Mall MA, Hartl D. CFTR: cystic fibrosis and beyond. Eur Respir J. 2014;44(4):1042-1054.
Muhlebach MS, Sha W. Lessons learned from metabolomics in cystic fibrosis. Mol Cell Pediatr. 2015;2:9.
Wetmore DR, Joseloff E, Pilewski J, et al. Metabolomic Profiling Reveals Biochemical Pathways and Biomarkers Associated with Pathogenesis in Cystic Fibrosis Cells. J Biol Chem. 2010;285(40):30516-30522.
Wolak JE, Esther CR Jr, O'Connell TM. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers. 2009;14(1):55-60.
Ferring M, Vincent JL. Is outcome from ARDS related to the severity of respiratory failure? Eur Respir J. 1997;10(6):1297-1300.
Lacy P. Metabolomics of sepsis-induced acute lung injury: a new approach for biomarkers. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L1-L3.
Banoei MM, Vogel HJ, Winston BW. Differentiating Sepsis-Induced Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) from Ventilated Intensive Care Unit (ICU) Controls Using Serum Metabolomics. In: B24. MECHANISMS OF INJURY IN SEPSIS: INFLAMMATION, OXIDATION, AND ENDOTHELIAL DAMAGE.A2563-A2563.
Izquierdo-Garcia JL, Nin N, Ruiz-Cabello J, et al. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med. 2011;37(12):2023-2032.
Seymour CW, Yende S, Scott MJ, et al. Metabolomics in pneumonia and sepsis: an analysis of the GenIMS cohort study. Intensive Care Med. 2013;39(8):1423-1434.
Zhou M-T, Chen C-S, Chen B-C, Zhang Q-Y, Andersson R. Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol. 2010;16(17):2094-2099.
Reilly JP, Bellamy S, Shashaty MG, et al. Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma. Ann Am Thorac Soc. 2014;11(5):728-736.
Xiao H, Huang JH, Zhang XW, et al. Identification of potential diagnostic biomarkers of acute pancreatitis by serum metabolomic profiles. Pancreatology. 2017;17(4):543-549.
Oresic M, Posti JP, Kamstrup-Nielsen MH, et al. Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury. EBioMedicine. 2016;12:118-126.
Cohen MJ, Serkova NJ, Wiener-Kronish J, Pittet JF, Niemann CU. 1H-NMR-based metabolic signatures of clinical outcomes in trauma patients--beyond lactate and base deficit. J Trauma. 2010;69(1):31-40.
Mao H, Wang H, Wang B, et al. Systemic metabolic changes of traumatic critically ill patients revealed by an NMR-based metabonomic approach. J Proteome Res. 2009;8(12):5423-5430.
Stringer KA, Serkova NJ, Karnovsky A, Guire K, Paine R, Standiford TJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol. 2010;300(1):L4-L11.
Park Y, Jones DP, Ziegler TR, et al. Metabolic effects of albumin therapy in acute lung injury measured by (1)H-NMR spectroscopy of plasma: a pilot study. Crit Care Med. 2011;39(10):2308-2313.
Greene K, Wright J, Steinberg K, et al. Serial Changes in Surfactant-associated Proteins in Lung and Serum before and after Onset of ARDS. Am J Respir Crit Care Med. 1999;160(6):1843-1850.
Doyle IR, Nicholas TE, Bersten AD. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152(1):307-317.
Jones AE, Puskarich MA, Karnovsky A, Serkova NJ. 1H-Nuclear Magnetic Resonance (NMR)-detected Lipids Associated With Apoptosis Differentiate Early Acute Respiratory Distress Syndrome (ARDS) from Sepsis. In: C63. LUNG INJURY AND REPAIR: TWO TO TANGO.A5000-A5000.
Singh C, Rai R, Azim A, et al. Metabolic profiling of human lung injury by 1H high-resolution nuclear magnetic resonance spectroscopy of blood serum. Metabolomics. 2015;11(1):166-174.
Ferrarini A, Righetti L, Martínez MP, et al. Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform. Electrophoresis. 2017;38(18):2341-2348.
Schubert JK, Muller WP, Benzing A, Geiger K. Application of a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med. 1998;24(5):415-421.
Rogers AJ, Contrepois K, Wu M, et al. Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset. Am J Physiol Lung Cell Mol Physiol. 2017;312(5):L703-L709.
Nakos G, Kitsiouli EI, Tsangaris I, Lekka ME. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Intensive Care Med. 1998;24(4):296-303.
Papazian L, Thomas P, Garbe L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1995;152(6 Pt 1):1982-1991.
Donnelly SC, Haslett C, Strieter RM, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 341(8846):643-647.
Azmi J, Connelly J, Holmes E, Nicholson JK, Shore RF, Griffin JL. Characterization of the biochemical effects of 1-nitronaphthalene in rats using global metabolic profiling by NMR spectroscopy and pattern recognition. Biomarkers. 2005;10(6):401-416.
Izquierdo-García JL, Naz S, Nin N, et al. A Metabolomic Approach to the Pathogenesis of Ventilator-induced Lung Injury. Anesthesiology. 2014;120(3):694-702.
Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, Stringer KA. Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295(1):L152-L161.
Evans CR, Karnovsky A, Kovach MA, Standiford TJ, Burant CF, Stringer KA. Untargeted LC-MS Metabolomics of Bronchoalveolar Lavage Fluid Differentiates Acute Respiratory Distress Syndrome from Health. J Proteome Res. 2014;13(2):640-649.
Singh C, Rai R, Azim A, Sinha N, Baronia A. Mini-bronchoalveolar lavage fluid can be used for biomarker identification in patients with lung injury by employing 1H NMR spectroscopy. Crit Care. 2013;17(2):430.
Singh C, Rai RK, Azim A, Sinha N, Baronia AK. Search for biomarkers in critically ill patients: a new approach based on nuclear magnetic resonance spectroscopy of mini-bronchoalveolar lavage fluid. Crit Care. 2014;18(6):594.
Rai R, Azim A, Sinha N, et al. Metabolic profiling in human lung injuries by high-resolution nuclear magnetic resonance spectroscopy of bronchoalveolar lavage fluid (BALF). Metabolomics. 2013;9(3):667-676.
Viswan A, Sharma RK, Azim A, Sinha N. NMR-Based Metabolic Snapshot from Minibronchoalveolar Lavage Fluid: An Approach To Unfold Human Respiratory Metabolomics. J Proteome Res. 2016;15(1):302-310.
Viswan A, Singh C, Rai RK, Azim A, Sinha N, Baronia AK. Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia. PLoS ONE. 2017;12(11):e0187545.
Viswan A, Ghosh P, Gupta D, Azim A, Sinha N. Distinct Metabolic Endotype Mirroring Acute Respiratory Distress Syndrome (ARDS) Subphenotype and its Heterogeneous Biology. Sci Rep. 2019;9(1):2108.
Kan M, Shumyatcher M, Himes BE. Using omics approaches to understand pulmonary diseases. Respir Res. 2017;18:149.
Meyer NJ. Beyond single-nucleotide polymorphisms: genetics, genomics, and other 'omic approaches to acute respiratory distress syndrome. Clin Chest Med. 2014;35(4):673-684.
Rogers AJ, Matthay MA. Applying metabolomics to uncover novel biology in ARDS. Am J Physiol Lung Cell Mol Physiol. 2014;306(11):L957-L961.
Snowden S, Dahlén S-E, Wheelock CE. Application of metabolomics approaches to the study of respiratory diseases. Bioanalysis. 2012;4(18):2265-2290.
Devillier P, Salvator H, Naline E, Couderc L-J, Grassin-Delyle S. Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases. Curr Pharm Des. 2017;23(14):2050-2059.
Wheelock CE, Goss VM, Balgoma D, et al. Application of’omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J. 2013;42(3):802-825.
Janz DR, Ware LB. Biomarkers of ALI/ARDS: Pathogenesis, Discovery, and Relevance to Clinical Trials. Semin Respir Crit Care Med. 2013;34(04):537-548.